Title  | Date  | Price  |
|---|
Commercial Insight: Antihormonal Cancer Therapies
| Jul 2009 |
£9,140 |
Pipeline and Commercial Insight: Obesity - the $11 billion market that never was
| Jul 2009 |
£9,140 |
Antihormonal Therapies Market Forecast
| Jul 2009 |
£9,140 |
Analyzing Edible Vaccines
| Jul 2009 |
£900 |
Global Vaccine Market Forecast to 2012
| Jun 2009 |
£1,200 |
Therapeutic Monoclonal Antibodies Markets
| Jun 2009 |
£1,235 |
Cytotoxic Therapies Market Forecast
| Jun 2009 |
£9,140 |
U.S. Market for Women's Health Devices 2009
| May 2009 |
£300 |
Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
| May 2009 |
£2,315 |
U.S. Compression Therapy Market
| May 2009 |
£3,605 |
European Markets for Parkinson's Disease Therapeutics
| May 2009 |
£3,910 |
Monoclonal Antibodies in Cancer Therapy 2009-2024
| May 2009 |
£1,499 |
World Vaccines Market 2008-2013 Future Forecast, Critical Trends and Developments
| Apr 2009 |
£480 |
Pipeline Insight: Benign Prostatic Hyperplasia - Novel therapeutics and reformulations will drive market growth
| Apr 2009 |
£6,950 |
Research Report in Vaccine Industry
| Apr 2009 |
£180 |
The Autoimmune Outlook to 2013 Competitive landscape, pipeline analysis and growth opportunities
| Apr 2009 |
£1,730 |
Research Report of Chinese Bird Flu Vaccine Industry, 2009
| Apr 2009 |
£990 |
ScientiaVision Product Pinpoint: The New Vaccines
| Mar 2009 |
£1,800 |
Stroke_Cardiovascular and Circulatory System Therapy Area Pipeline Report
| Mar 2009 |
£925 |
Arrhythmiasis Therapy Area Pipeline Report
| Mar 2009 |
£925 |
Direct-To-Consumer Genetic Testing Business Prospects in the United States
| Mar 2009 |
£2,255 |
Stroke_Central Nervous System Therapy Area Pipeline Report
| Mar 2009 |
£925 |
Research Report on China's Foot-and-Mouth Disease Vaccine (FMD Vaccine) Industry, 2009
| Mar 2009 |
£495 |
Research Report on China's Animal Vaccine Industry, 2009
| Mar 2009 |
£1,050 |
Chinese Markets for Incretion Drugs
| Feb 2009 |
£2,405 |
Women's Health: Worldwide Prescription Drug Markets, 4th Edition
| Feb 2009 |
£1,800 |
Stem Cell Therapeutics Markets
| Feb 2009 |
£1,505 |
Freedonia Focus on Vaccines
| Feb 2009 |
£310 |
Analytical Tool - Cancer Therapeutic Antibodies
| Jan 2009 |
£3,750 |
Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013
| Jan 2009 |
£6,185 |
Dermatological Therapeutics Global Markets
| Jan 2009 |
£2,915 |
Analytical Tool - Vaccines
| Jan 2009 |
£2,835 |
Delivering New Biopharmaceutical Therapies Challenges & Opportunities
| Jan 2009 |
£945 |
Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)
| Jan 2009 |
£2,105 |
Analytical Tool - Colorectal Cancer
| Jan 2009 |
£2,835 |
Analytical Tool - Protein Kinase Inhibitors in Oncology
| Jan 2009 |
£2,835 |
Analytical Tool - Angiogenesis in Oncology
| Jan 2009 |
£2,835 |
Therapeutics for Memory and Cognition Disorders
| Jan 2009 |
£2,915 |
Dermatological Therapeutics: Global Markets
| Jan 2009 |
£2,915 |
Stem Cell-Based Therapeutic Delivery Challenges & Opportunities
| Dec 2008 |
£945 |
U.S. Radiotherapy Market
| Dec 2008 |
£3,605 |
Protein Therapeutics Markets (Antithrobins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments)
| Dec 2008 |
£2,100 |
Booming Global Obesity Drug Market
| Dec 2008 |
£465 |
Stakeholder Opinions: Bladder Cancer New drugs needed to challenge ineffective 20year old drugs
| Nov 2008 |
£2,315 |
Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis 3rd Edition
| Nov 2008 |
£2,400 |
Immunotherapies and Vaccines for Cancer and Infectious Diseases
| Oct 2008 |
£2,255 |
Therapeutic Apheresis
| Oct 2008 |
£2,375 |
Oncology Market Leaders Analyses and Outlook, Market Report 2008 - 2023
| Oct 2008 |
£1,499 |
Women's Reproductive Disorders Therapeutics 2008-2018
| Sep 2008 |
£1,499 |
European Vaccines Market
| Sep 2008 |
£3,910 |
Strategic Analysis of the Oncology Services in Sub-Saharan Africa
| Sep 2008 |
£3,605 |
European Therapeutic Monoclonal Antibody Markets
| Aug 2008 |
£3,910 |
Cancer Therapeutics Market Insight and R&D Pipeline Analysis
| Aug 2008 |
£2,105 |
The Global Vaccines Market,
2008-2023
| Aug 2008 |
£1,499 |
China Vaccine Market Report 2007-2009
| Jul 2008 |
£1,200 |
Oncology Market Forecast to 2013
| Jul 2008 |
£10,090 |
Obesity Drug Markets in the US and EU Analysis of product pipelines and the competitive environment
| Jul 2008 |
£2,305 |
Stakeholder Opinions: Hormonal Treatments for Menopausal Symptoms - Market Open to Takers as Tepid Pipeline Fails to Meet Demand
| Jun 2008 |
£2,315 |
Antibiotics
| May 2008 |
£2,375 |
Human Vaccines
| May 2008 |
£2,375 |
Indian Aesthetic (Cosmetic Surgery) Industry: A Primer
| May 2008 |
£1,510 |
Pipeline Insight: Non-Small Cell Lung Cancer Pipeline set to offer only modest improvements
| Apr 2008 |
£6,885 |
Pipeline Insight: Breast Cancer Recent approvals increase pressure on pipeline candidates
| Apr 2008 |
£6,885 |
Pipeline Insight: Nosocomial Vaccines Minefield or Goldmine?
| Apr 2008 |
£6,885 |
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
| Apr 2008 |
£2,055 |
Clinical Information Systems in Europe - Oncology
| Apr 2008 |
£3,910 |
South Africa Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Egypt Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Republic of Korea Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Mexico Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Israel Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Argentina Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Germany Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
North America Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Europe Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Belgium Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Australia Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Brazil Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
France Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
US Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Asia Pacific Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Japan Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
South & Central America Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Netherlands Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
The Future of Targeted Therapeutics Key Technologies, New Therapy Area Applications and Leading Players
| Mar 2008 |
£2,305 |
Middle East & Africa Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Spain Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Canada Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Italy Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
UK Neurology Devices Industry Report
| Mar 2008 |
£1,855 |
Vaccines
| Mar 2008 |
£600 |
Strategic Analysis of the South African Paediatric Vaccines Markets
| Feb 2008 |
£3,605 |
Standard and Speciality Medical Beds and Therapeutic Surfaces Worldwide
| Feb 2008 |
£1,200 |
U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook
| Jan 2008 |
£3,605 |
U.S. Infectious Disease Vaccine Pipeline
| Jan 2008 |
£3,605 |
Stakeholder Opinions: Multiple Myeloma Exploring New Targets for Multiple Drug Therapy
| Dec 2007 |
£2,280 |
Pipeline Insight:Orphan Diseases in CNS - Part II Amyotrophic Lateral Sclerosis
| Dec 2007 |
£4,570 |
Premium Company Profile: Neurocrine Biosciences Inc
| Nov 2007 |
£300 |
Global Vaccine Market Outlook (2007-2010)
| Nov 2007 |
£960 |
Decoding Big Pharma's R&D Strategy in Oncology
| Sep 2007 |
£1,790 |